4 research outputs found

    Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    Get PDF

    New Perspectives on Ofloxacin: Proceedings of a Symposium Held in West Berlin, 16 October 1989

    No full text

    Podocytopathies

    No full text
    corecore